Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study

Mostrar otras versiones (1)

BACKGROUND: Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. Although DCIS is generally highly curable, some women with DCIS will develop life-threatening invasive breast cancer, but the determinants of progression to infiltrating ductal can...

Descripción completa

Detalles Bibliográficos
Autores principales: Moelans, Cathy B., de Wegers, Roel A., Monsuurs, Hanneke N., Maess, Anoek H. J., van Diest, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219861/
https://www.ncbi.nlm.nih.gov/pubmed/21547576
http://dx.doi.org/10.1007/s13402-011-0043-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219861/
https://www.ncbi.nlm.nih.gov/pubmed/21547576
http://dx.doi.org/10.1007/s13402-011-0043-7

Ejemplares similares